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Familial Mediterranean fever is caused bymutations of the PYRIN protein. Chae et al. (2011) provide evidence
for a ASC protein-dependent pathway of caspase-1 activation in which gain-of-function PYRIN mutations
lead to IL-1b cytokine overproduction and inflammatory disease.Autoinflammatory syndromes are rare
disorders characterized by recurrent epi-
sodes of systemic inflammation and fever
in the absence of microbial infection or
autoimmunity. Accumulating evidence
indicate that these diseases are caused
by abnormal activation of the innate im-
mune system with little or no involvement
of T and B cells. Familial Mediterranean
fever (FMF), a disease that is prevalent
among Eastern Mediterranean popula-
tions, is the most frequent autoinflamma-
tory disorder and is caused by inherited
mutations in the MEFV gene, which
encodes a 781 amino acid protein known
as PYRIN (Kastner et al., 2010). Human
PYRIN consists of an N-terminal Pyrin
domain (PYD) linked to two central
B-box zinc-finger and coiled-coil domains
and a C-terminal B30.2 domain (also
called SPRY). To date, more than 50
FMF-associated PYRIN mutations have
been identified, most of which are clus-
tered within the B30.2 domain, which is
surprisingly absent in mouse Pyrin. FMF
has been traditionally considered a re-
cessive disorder in that in most patients,
both PYRIN alleles aremutated. However,
there is also evidence that disease can
occur in some patients harboring a
single mutated PYRIN allele (Kastner
et al., 2010). Furthermore, up to 20% ofFMF patients lack identifiable PYRIN
mutations.
Although thecasual linkbetweenPYRIN
mutations and FMF is well established,
there is controversy about the physiolog-
ical role of PYRIN and how PYRIN muta-
tions promote disease. Initial experiments
with mice expressing a truncated form of
mouse PYRIN suggested that PYRIN
functions as a negative regulator of cas-
pase-1 activation (Chae et al., 2003).
PYRIN was suggested to compete with
caspase-1 for binding toASC, aPYD-con-
taining adaptor protein that links nucleo-
tide-binding domain and leucine-rich
repeat containing proteins (NLRs) to
pro-caspase-1 in several inflammasome
pathways (Franchi et al., 2009). The main
function of caspase-1 is to induce the
maturation and secretion of the proinflam-
matory cytokines IL-1b and IL-18. Mice
expressing only the PYD domain were
more susceptible to stimulation with lipo-
polysaccharide (LPS), and macrophages
stimulated with LPS produced more
IL-1b. These data are consistent with a
model in which full-length PYRIN, but not
its truncated version consisting of only
the PYD domain, acts as a negative regu-
lator of caspase-1. In linewith an inhibitory
role, PYRIN was found to associate with
inflammasome components includingNLRP3, ASC, and caspase-1, which
can disrupt the interaction between cas-
pase-1 and ASC and lead to reduced
caspase-1 activation (Chae et al., 2006;
Dowds et al., 2003; Papin et al., 2007).
However, the resultswithmice expressing
a truncated PYRIN are open to an alterna-
tive interpretation. PYRIN may promote
the activation of caspase-1 by interacting
with ASC, but this is normally blocked in
the full-length protein where PYRIN is
kept in an inactive conformation. Consis-
tent with this second possibility, some
studies showed that PYRIN promotes
ASC dimerization and caspase-1 activa-
tion (Seshadri et al., 2007; Yu et al., 2006).
In linewith a positive role for PYRIN,proline
serine threonine phosphatase-interacting
protein 1 (PSTPIP1), a protein that is
mutated in PAPA syndrome, another
FMF-related autoinflammatory disorder,
binds to and activates PYRIN, which pro-
motes ASC dimerization and caspase-1
activation (Yu et al., 2007). Notably,
PAPA-associated PSTPIP1 mutants ex-
hibited an enhanced ability to induce
PYRINactivation (Yuetal., 2007). The latter
work suggests that PSTPIP1 and PYRIN
are components of a molecular pathway
that leads to caspase-1 activation.
In this issue of Immunity, Chae et al.
(2011) report the development of a mouse34, May 27, 2011 ª2011 Elsevier Inc. 695
Figure 1. Proposed Model for Caspase-1 Activation Pathway
Regulated by Mutant and Wild-Type PYRIN
FMF-associated PYRIN mutants positively promote ASC-dependent cas-
pase-1 activation, leading to inappropriate secretion of mature IL-1b. The
precise role of human and mouse PYRIN in caspase-1 activation remains
unclear.
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Previewsmodel of FMF in which mice
are engineered to express
the mouse Pyrin protein fused
to the human B30.2 domain
with missense mutations
associated with FMF (referred
to here as Pyrin-mB30.2).
Because mouse Pyrin lacks
the commonly mutated
B30.2 domain, the generation
of mice expressing Pyrin-
mB30.2 provides the oppor-
tunity to investigate the role
of pathogenic B30.2
missense mutations in this
mouse model. The authors
tested three strains of Pyrin-
mB30.2 knockin mice that
carried the most common
PYRIN mutations found in
FMF patients. They observed
that homozygous mutant
mice, but not heterozygous
animals, developed inflam-
mation in multiple tissues
characterized by marked infil-
tration of neutrophils and
macrophages. These results
indicate that both alleles
need to be mutated for
disease development and
suggest that Pyrin-mB30.2
knockin mice represent anappropriate model to investigate how
B30.2 domain mutations trigger disease.
The fact that only homozygous mice
develop inflammatory disease is consis-
tentwith the recessivemodeof inheritance
for FMF and with a loss-of-function role
for B30.2 domain mutations. However,
Chae et al. (2011) also generated Pyrin-
null mice and found that these mutant
mice developed normally, indicating
that the functional role of Pyrin-mB30.2
and Pyrin is different. To further clarify
the function of chimeric Pyrin-mB30.2,
the authors generated hemizygous
Pyrin-mB30.2 and Pyrin mice. These
mice expressed a single Pyrin-mB30.2
allele in the absence of endogenous Pyrin
and were grossly normal without signs
of inflammation. Because Pyrin-mB30.2
homozygous mice expressed higher
amounts of the chimeric protein than did
hemizygous mice, the authors suggested
a model in which B30.2 domain mutations
in fact act as gain-of-function mutations
such that there was a mutant protein
dosage effect in inducing disease.696 Immunity 34, May 27, 2011 ª2011 ElseviIn agreement with a critical role for IL-1b
in disease, Chae et al. (2011) showed that
systemic inflammation was ablated in
Pyrin-mB30.2mice lacking IL-1R signaling
but proceeded undisturbed in Rag-1
mutant mice, which are deficient in adap-
tive immunity. Because activation of
caspase-1 is controlled by the inflamma-
somes, molecular platforms that guide
the dimerization and activation of cas-
pase-1, the authors tested the role of the
NLRP3 inflammasome that is activated
by different signals including cellular
damage, particulate matter, and pore-
forming toxins. They found that Pyrin-
mB30.2 mice deficient in NLRP3 devel-
oped systemic inflammation whereas
those null for ASC did not. These results
are consistent with a model in which
mutant PYRIN mediates the activation
of caspase-1 via ASC independently of
NLRP3 (Figure 1). Notably, analysis of
macrophages deficient in Pyrin revealed
that this protein was dispensable for cas-
pase-1 activation induced via several in-
flammasomes including NLRP3, NLRC4,er Inc.and Aim2. It remains to be
determined whether PYRIN is
anadaptorofanasyetunchar-
acterized NLR inflammasome
or represents a component
of a novel ASC-dependent
caspase-1 activation pathway
(Figure 1). Furthermore, the
stimuli that physiologically
lead to PYRIN activation
remain to be elucidated.
Although the studies by
Chae et al. (2011) provide
new insight into the role of
PYRIN in the regulation of
caspase-1 activation and
autoinflammatory disease,
there is one caveat that limits
somewhat the interpretation
of this work. Although at first
glance, chimeric Pyrin-
mB30.2 mice provide a valu-
able model to study the role
of missense B30.2 mutations
in disease, it is plausible that
expression of a human
domain that is not present in
wild-type mice leads to
unforeseen artifacts. The
observation that expression
of the chimeric Pyrin protein
fused to the wild-type B30.2
domain may be embryoniclethal even in heterozygotes mice is
puzzling. Thus, an alternative interpreta-
tion of the results is that a single allele of
chimeric Pyrin fused to wild-type B30.2
is sufficient to induce embryonic lethality
and, therefore, Pyrin-mB30.2 represents
a loss-of-function mutation requiring two
alleles for disease in the adult.
In summary, Chae et al. (2011) have
developed a potentially useful model of
FMF that suggests that missense PYRIN
mutations associated with the disease
are gain-of-function mutations with
a dosage effect. Moreover, the authors
clearly showed that in this mouse model,
disease progression is dependent on
IL-1 signaling and ASC. Recent reports
indicate that IL-1 blockade in FMF is
beneficial when treatment with colchicine,
the drug typically use to treat disease, is
ineffective. Therefore, this study provides
a molecular rationale for targeting IL-1b in
FMF. Consistent with this, the authors
found that stimulation with LPS or LPS
plus ATP induces enhanced activation of
caspase-1 and maturation of IL-1b in
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Previewsmacrophages from FMF patients when
compared to cells from healthy individ-
uals. It remains unclear, however, what
the physiological role of PYRIN is in
the activation of caspase-1 and the
ASC-dependent pathway that PYRIN
regulates. These important questions will
be the subject of future investigation.
REFERENCES
Chae, J.J., Komarow, H.D., Cheng, J., Wood, G.,
Raben, N., Liu, P.P., and Kastner, D.L. (2003).
Mol. Cell 11, 591–604.Chae, J.J., Wood, G., Masters, S.L., Richard, K.,
Park, G., Smith, B.J., and Kastner, D.L. (2006).
Proc. Natl. Acad. Sci. USA 103, 9982–9987.
Chae, J.J., Cho, Y.-H., Lee, G.-S., Cheng, J.,
Liu, P.P., Feigenbaum, L., Katz, S.I., and
Kastner, D.L. (2011). Immunity 34, this issue,
755–768.
Dowds, T.A., Masumoto, J., Chen, F.F., Ogura, Y.,
Inohara, N., and Nu´n˜ez, G. (2003). Biochem. Bio-
phys. Res. Commun. 302, 575–580.
Franchi, L., Eigenbrod, T., Mun˜oz-Planillo, R., and
Nun˜ez, G. (2009). Nat. Immunol. 10, 241–247.
Kastner, D.L., Aksentijevich, I., and Goldbach-
Mansky, R. (2010). Cell 140, 784–790.ImmunityPapin, S., Cuenin, S., Agostini, L., Martinon, F.,
Werner, S., Beer, H.D., Gru¨tter, C., Gru¨tter, M.,
and Tschopp, J. (2007). Cell Death Differ. 14,
1457–1466.
Seshadri, S., Duncan, M.D., Hart, J.M., Gavrilin,
M.A., and Wewers, M.D. (2007). J. Immunol. 179,
1274–1281.
Yu, J.W., Wu, J., Zhang, Z., Datta, P., Ibrahimi, I.,
Taniguchi, S., Sagara, J., Fernandes-Alnemri, T.,
and Alnemri, E.S. (2006). Cell Death Differ. 13,
236–249.
Yu, J.W., Fernandes-Alnemri, T., Datta, P., Wu, J.,
Juliana, C., Solorzano, L., McCormick, M., Zhang,
Z., and Alnemri, E.S. (2007). Mol. Cell 28, 214–227.A Narrow Circle of Mutual FriendsAlexander Y. Rudensky1,* and Alexander V. Chervonsky2,*
1Howard Hughes Medical Institute and Immunology Program, Sloan Kettering Institute, New York, NY 10021, USA
2Department of Pathology, University of Chicago, Chicago, IL 60637, USA
*Correspondence: rudenska@mskcc.org (A.Y.R.), achervon@bsd.uchicago.edu (A.V.C.)
DOI 10.1016/j.immuni.2011.05.008
Commensal microbiota confers a goldilocks state of alertness to pathogens, yet restrains deleterious inflam-
mation. In this issue of Immunity, Geuking et al. (2011) demonstrate that a minimal bacterial community of the
Schaedler flora establishes a balance between pro- and anti-inflammatory T cells in the gut.Coevolution of metazoans and microor-
ganisms has been driven by multifaceted
cross-kingdom symbioses affecting nu-
trient and energy consumption, immune
defense, detoxification, tissue repair, and
organ morphogenesis. Evolutionarily con-
served mutualistic relationships between
metazoan hosts and their symbiotic and
commensal microbiota have been most
intensely studied in the context of
mammalian gut because of their imme-
diate medical relevance. The gut harbors
highly complex, species-specificmicrobial
communities whose composition both
influences and is influenced by the innate
and adaptive immune system. ‘‘Tonic’’
stimulation affordedby the immune recog-
nition of commensalmicroorganisms facil-
itates the development of the mucosal
immune system and confers resistance to
infection. Besides induction of secreted
mediators of the immune responses
(antimicrobial peptides, chemokines, and
cytokines) and intracellular immune
effectors and recruitment and activation
of innate immune cells, the adaptive armof the immune system is also profoundly
affected by the commensal microbiota
(Garrett et al., 2010). The latter notion
comes from observations in germ-free
mice where CD4+ T cells exhibit
pronounced skewing toward production
of T helper 2 (Th2) cell cytokines, whereas
Th1 cell cytokine production is sharply
diminished. Most notable, however, is the
essentially complete absence of IL-17-
and IL-22-producing Th17 cells and
diminished expression of IL-23. In agree-
mentwith thesefindings,prolongedantibi-
otic treatment of conventionally housed
animals leads to a diminished expression
of proinflammatory Th17 and Th1 cell
cytokines. Consequently, decreased
amounts of IL-17, IL-22, and IL-23 lead to
increased susceptibility to infection with
intestinal pathogens such as Citrobacter
rodentium (Ivanov et al., 2009).
Commensal microbiota is also required
for TGF-b-dependent IgA production. In
addition to immune response and inflam-
mation-promoting effect, commensal
microbiota facilitates elaboration of anti-inflammatory mechanisms in the gut,
including IL-10 production and increase
in numbers of suppressive T cells,
i.e., both Foxp3-expressing regulatory T
(Treg) cells and Foxp3-negative, IL-10-
producing Tr1 cells. When the immuno-
logical balance in the gut is tipped toward
immune responses against commensal
and opportunistic microbes, unwanted
local and systemic maladies ensue, as
suggested by several recent studies in
experimental mouse models (Garrett
et al., 2010). In particular, Th17 cell gener-
ation can facilitate diverse pathologies
including colitis, inflammatory bowel
disease, and arthritis (Ivanov et al., 2009;
Wu et al., 2010). These unwanted
consequences of overexuberant effector
responses or inadequate negative regula-
tion of the immune stimulation by gut
microbiota are dependent on a genetic
background of the host and thus are
likely inconsequential at a species level.
Thus, under physiologic conditions, the
bacterial community in the gut promotes
inflammatory responses capable of34, May 27, 2011 ª2011 Elsevier Inc. 697
